Christoph Wanner

Christoph Wanner i

Universität Würzburg - Würzburg / Germany
Others
AD Scientific Index ID: 1788431
University of Würzburg
person_outline Christoph Wanner's MOST POPULAR ARTICLES
1-) Heart disease and stroke statistics—2016 update: a report from the American Heart AssociationD Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ...circulation 133 (4), e38-e360, 201641045*2016
2-) Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetesB Zinman, C Wanner, JM Lachin, D Fitchett, E Bluhmki, S Hantel, ...New england journal of medicine 373 (22), 2117-2128, 2015105222015
3-) 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with …FLJ Visseren, F Mach, YM Smulders, D Carballo, KC Koskinas, M Bäck, ...European journal of preventive cardiology 29 (1), 5-115, 202239752022
4-) Cardiovascular and renal outcomes with empagliflozin in heart failureM Packer, SD Anker, J Butler, G Filippatos, SJ Pocock, P Carson, ...New England Journal of Medicine 383 (15), 1413-1424, 202046102020
5-) Empagliflozin and progression of kidney disease in type 2 diabetesC Wanner, SE Inzucchi, JM Lachin, D Fitchett, M von Eynatten, ...New England Journal of Medicine 375 (4), 323-334, 201639752016